FdaApplication
ANDA 203704
Identifiers
- fda_app_no: ANDA203704
Properties
| Property | Value |
|---|---|
| applicant_name | QILU ANTIBIOTICS PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2016-02-01 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
| CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
3 products